ANIVIVE

Trademark usage description

nutraceuticals for use as a dietary supplement for general health and well-being in the field of veterinary medicine; veterinary pharmaceutical anti-v Read More

Classification Information

Class [005]
Nutraceuticals for use as a dietary supplement for general health and well-being in the field of veterinary medicine; veterinary pharmaceutical anti-viral agents; veterinary vaccines; veterinary pharmaceutical preparations for the treatment of infectious diseases in cats and dogs; veterinary pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders; veterinary pharmaceutical preparations in the nature of fungal medications; vaccines in the field of veterinary medicine; veterinary therapeutic pharmaceutical anti-viral agents; veterinary therapeutic pharmaceutical preparations for the treatment of infectious diseases in cats and dogs; veterinary therapeutic pharmaceutical preparations for the diagnosis and treatment of oncological diseases and disorders; veterinary therapeutic pharmaceutical preparations in the nature of fungal medications;

Classification kind code

Class [009]
Computer software and software platforms for assisting in drug discovery and managing clinical trials for animals; computer software and software platforms to facilitate ordering and delivery of medications and treatment to animal owners, distributors and veterinary health care providers;

Classification kind code

Mark Details

Serial Number

1997879

Mark Type

Trademark

Legal History

Action Taken	Status
Submitted for opposition 42 on 29^th Jan 2025	Advertised
Submitted for opposition 26 on 3^rd Jan 2025	Approved
Submitted for opposition 27 on 3^rd Jan 2025	Approval Notice Sent
Submitted for opposition 22 on 15^th May 2024	Search Recorded
Submitted for opposition 20 on 15^th May 2024	Examiner's First Report
Submitted for opposition 287 on 6^th Jun 2022	Pre-Assessment Letter Sent
Submitted for opposition 31 on 9^th Dec 2019	Formalized
Submitted for opposition 1 on 27^th Nov 2019	Created
Submitted for opposition 30 on 26^th Nov 2019	Filed